Review



anti human pd 1 antibody  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc anti human pd 1 antibody
    a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of <t>PD-1–PD-L1</t> inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.
    Anti Human Pd 1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 216 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/PD-1+XP+Rabbit+mAb/bio_rxiv__64898__2026__03__28__715001-272-25-28
    Average 96 stars, based on 216 article reviews
    anti human pd 1 antibody - by Bioz Stars, 2026-10
    96/100 stars

    Images

    1) Product Images from "Quantitative extrapolation from single-tags (QuEST) immunofluorescence microscopy to derive TCR signalosome stoichiometries in human primary T cells"

    Article Title: Quantitative extrapolation from single-tags (QuEST) immunofluorescence microscopy to derive TCR signalosome stoichiometries in human primary T cells

    Journal: bioRxiv

    doi: 10.64898/2026.03.28.715001

    a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of PD-1–PD-L1 inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.
    Figure Legend Snippet: a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of PD-1–PD-L1 inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.

    Techniques Used: Expressing, Two Tailed Test

    Related Articles

    Expressing:

    Article Title: Quantitative extrapolation from single-tags (QuEST) immunofluorescence microscopy to derive TCR signalosome stoichiometries in human primary T cells
    Article Snippet: Unlabelled primary antibodies : anti-human CD8α antibody (Cell Signaling Technology, Cat#85336), anti-human CD28 antibody (Cell Signaling Technology, Cat#38774S), anti-human CD45 antibody (Cell Signaling Technology, Cat#13917S), anti-human PD-1 antibody (Cell Signaling Technology, Cat#86163T), anti-human Lck antibody (Cell Signaling Technology, Cat#2787S), anti-human ZAP-70 antibody (Cell Signaling Technology, Cat#3165S), anti-human LAT antibody (Cell Signaling Technology, Cat#45533S), anti-human PLCγ1 antibody (Cell Signaling Technology, Cat#5690S), and anti-human phospho-ZAP-70 (Tyr319) antibody (Cell Signaling Technology, Cat#2701).

    Two Tailed Test:

    Article Title: Quantitative extrapolation from single-tags (QuEST) immunofluorescence microscopy to derive TCR signalosome stoichiometries in human primary T cells
    Article Snippet: Unlabelled primary antibodies : anti-human CD8α antibody (Cell Signaling Technology, Cat#85336), anti-human CD28 antibody (Cell Signaling Technology, Cat#38774S), anti-human CD45 antibody (Cell Signaling Technology, Cat#13917S), anti-human PD-1 antibody (Cell Signaling Technology, Cat#86163T), anti-human Lck antibody (Cell Signaling Technology, Cat#2787S), anti-human ZAP-70 antibody (Cell Signaling Technology, Cat#3165S), anti-human LAT antibody (Cell Signaling Technology, Cat#45533S), anti-human PLCγ1 antibody (Cell Signaling Technology, Cat#5690S), and anti-human phospho-ZAP-70 (Tyr319) antibody (Cell Signaling Technology, Cat#2701).



    Similar Products

    pd 1  (Miltenyi Biotec)
    93
    Miltenyi Biotec pd 1
    Pd 1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/CD279+(PD1)+Antibody%2C+anti-human%2C+REAfinity/pm42455847-67-88-90
    Average 93 stars, based on 1 article reviews
    pd 1 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    anti pd 1  (Miltenyi Biotec)
    93
    Miltenyi Biotec anti pd 1
    Anti Pd 1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/CD223+Antibody%2C+anti-human%2C+REAfinity/pm42097413-68-36-37
    Average 93 stars, based on 1 article reviews
    anti pd 1 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    anti human pd 1 antibody  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc anti human pd 1 antibody
    a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of <t>PD-1–PD-L1</t> inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.
    Anti Human Pd 1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/PD-1+XP+Rabbit+mAb/bio_rxiv__64898__2026__03__28__715001-272-25-28
    Average 96 stars, based on 1 article reviews
    anti human pd 1 antibody - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    mouse anti human pd 1  (Cell Signaling Technology Inc)
    86
    Cell Signaling Technology Inc mouse anti human pd 1
    a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of <t>PD-1–PD-L1</t> inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.
    Mouse Anti Human Pd 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/pm41923619-322-40-43
    Average 86 stars, based on 1 article reviews
    mouse anti human pd 1 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    fczero rabtm apc anti human pd  (Proteintech)
    97
    Proteintech fczero rabtm apc anti human pd
    a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of <t>PD-1–PD-L1</t> inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.
    Fczero Rabtm Apc Anti Human Pd, supplied by Proteintech, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/Histone+H4+Antibody/pm41903590-55-9-32
    Average 97 stars, based on 1 article reviews
    fczero rabtm apc anti human pd - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    fczero rabtm apc anti human pd l1 cd274 rabbit recombinant antibody  (Proteintech)
    98
    Proteintech fczero rabtm apc anti human pd l1 cd274 rabbit recombinant antibody
    a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of <t>PD-1–PD-L1</t> inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.
    Fczero Rabtm Apc Anti Human Pd L1 Cd274 Rabbit Recombinant Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/PD-L1%2FCD274+Antibody/pm41903590-55-21-32
    Average 98 stars, based on 1 article reviews
    fczero rabtm apc anti human pd l1 cd274 rabbit recombinant antibody - by Bioz Stars, 2026-10
    98/100 stars
    		  Buy from Supplier
    europe bv 3176021b cd274 pd l1 mih1 fluidigm europe bv 3209014b bacterial  (fluidigm)
    94
    fluidigm europe bv 3176021b cd274 pd l1 mih1 fluidigm europe bv 3209014b bacterial
    a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of <t>PD-1–PD-L1</t> inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.
    Europe Bv 3176021b Cd274 Pd L1 Mih1 Fluidigm Europe Bv 3209014b Bacterial, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/Anti-Human+CD282%2FTLR2+(TL2%2E1)-176Yb/pm41895259-232-125-130
    Average 94 stars, based on 1 article reviews
    europe bv 3176021b cd274 pd l1 mih1 fluidigm europe bv 3209014b bacterial - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    pd 1 pe  (Miltenyi Biotec)
    94
    Miltenyi Biotec pd 1 pe
    Low-affinity CD5 CAR-T cells exhibit reduced fratricide and exhaustion phenotypes (A) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (B) Culture supernatants were collected on day 3 after cell seeding. IFN-γ and TNF-α levels secreted by CAR -T cells were measured by cytometric bead array. Data are presented as mean ± SD from multiple donors ( n = 3). (C) CD69 expression level of CAR-T cells on day 10 after seeding. Fluorescence intensity was quantified by flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (E) Expression levels <t>of</t> <t>PD-1</t> and LAG-3 (surface markers), and TOX (intracellular marker) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining following fixation and permeabilization. Data are presented as mean ± SD from multiple donors ( n = 3). All statistical significance was assessed using a linear mixed-effects model with donor as a random effect and Tukey’s test.
    Pd 1 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/CD274+(B7-H1)+Antibody%2C+anti-human%2C+REAfinity/pmc12969026-254-40-47
    Average 94 stars, based on 1 article reviews
    pd 1 pe - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    anti pd 1 pe vio770  (Miltenyi Biotec)
    94
    Miltenyi Biotec anti pd 1 pe vio770
    Low-affinity CD5 CAR-T cells exhibit reduced fratricide and exhaustion phenotypes (A) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (B) Culture supernatants were collected on day 3 after cell seeding. IFN-γ and TNF-α levels secreted by CAR -T cells were measured by cytometric bead array. Data are presented as mean ± SD from multiple donors ( n = 3). (C) CD69 expression level of CAR-T cells on day 10 after seeding. Fluorescence intensity was quantified by flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (E) Expression levels <t>of</t> <t>PD-1</t> and LAG-3 (surface markers), and TOX (intracellular marker) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining following fixation and permeabilization. Data are presented as mean ± SD from multiple donors ( n = 3). All statistical significance was assessed using a linear mixed-effects model with donor as a random effect and Tukey’s test.
    Anti Pd 1 Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/CD279+(PD1)+Antibody%2C+anti-human%2C+REAlease/10__1158_slash_2326___6066__cir___25___0605-197-59-60
    Average 94 stars, based on 1 article reviews
    anti pd 1 pe vio770 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    3174020b  (fluidigm)
    93
    fluidigm 3174020b
    Low-affinity CD5 CAR-T cells exhibit reduced fratricide and exhaustion phenotypes (A) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (B) Culture supernatants were collected on day 3 after cell seeding. IFN-γ and TNF-α levels secreted by CAR -T cells were measured by cytometric bead array. Data are presented as mean ± SD from multiple donors ( n = 3). (C) CD69 expression level of CAR-T cells on day 10 after seeding. Fluorescence intensity was quantified by flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (E) Expression levels <t>of</t> <t>PD-1</t> and LAG-3 (surface markers), and TOX (intracellular marker) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining following fixation and permeabilization. Data are presented as mean ± SD from multiple donors ( n = 3). All statistical significance was assessed using a linear mixed-effects model with donor as a random effect and Tukey’s test.
    3174020b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+pd+1+antibody/Anti-Human+CD279%2FPD-1+(EH12%2E2H7)-174Yb/pmc13006393-99-9-5
    Average 93 stars, based on 1 article reviews
    3174020b - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of PD-1–PD-L1 inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.

    Journal: bioRxiv

    Article Title: Quantitative extrapolation from single-tags (QuEST) immunofluorescence microscopy to derive TCR signalosome stoichiometries in human primary T cells

    doi: 10.64898/2026.03.28.715001

    Figure Lengend Snippet: a – c , Workflow ( a ), representative TIRF images ( b ), and quantification results ( c ) of the number of signaling molecules per TCR following introduction of PD-1–PD-L1 inhibitory signaling in T cells. d , Stoichiometry of the TCR signalosome under PD-1–PD-L1 inhibitory signaling. e , Quantified sensitivity of signaling molecules within the TCR signalosome to PD-1–PD-L1 inhibitory signaling. f , Generation of T cells expressing low or high levels of PD-1. g , h , Representative TIRF images ( g ) and corresponding quantification results ( h ) of the number of signaling molecules per TCR in T cells expressing low or high levels of PD-1, with or without PD-1–PD-L1 inhibitory signaling. Data in f are presented as mean ± SD; data in c , d , and h are presented as mean ± SEM. In c , d , and h , ≥30 individual cells were analyzed per condition. Statistical significance was assessed using an unpaired two-tailed Student’s t -test (*** P ≤ 0.001). Data in c , d , and h are representative of two replicates using T cells from two blood donors. Data in f are representative of three replicates using T cells from three blood donors.

    Article Snippet: Unlabelled primary antibodies : anti-human CD8α antibody (Cell Signaling Technology, Cat#85336), anti-human CD28 antibody (Cell Signaling Technology, Cat#38774S), anti-human CD45 antibody (Cell Signaling Technology, Cat#13917S), anti-human PD-1 antibody (Cell Signaling Technology, Cat#86163T), anti-human Lck antibody (Cell Signaling Technology, Cat#2787S), anti-human ZAP-70 antibody (Cell Signaling Technology, Cat#3165S), anti-human LAT antibody (Cell Signaling Technology, Cat#45533S), anti-human PLCγ1 antibody (Cell Signaling Technology, Cat#5690S), and anti-human phospho-ZAP-70 (Tyr319) antibody (Cell Signaling Technology, Cat#2701).

    Techniques: Expressing, Two Tailed Test

    Low-affinity CD5 CAR-T cells exhibit reduced fratricide and exhaustion phenotypes (A) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (B) Culture supernatants were collected on day 3 after cell seeding. IFN-γ and TNF-α levels secreted by CAR -T cells were measured by cytometric bead array. Data are presented as mean ± SD from multiple donors ( n = 3). (C) CD69 expression level of CAR-T cells on day 10 after seeding. Fluorescence intensity was quantified by flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (E) Expression levels of PD-1 and LAG-3 (surface markers), and TOX (intracellular marker) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining following fixation and permeabilization. Data are presented as mean ± SD from multiple donors ( n = 3). All statistical significance was assessed using a linear mixed-effects model with donor as a random effect and Tukey’s test.

    Journal: Molecular Therapy Oncology

    Article Title: Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells

    doi: 10.1016/j.omton.2026.201158

    Figure Lengend Snippet: Low-affinity CD5 CAR-T cells exhibit reduced fratricide and exhaustion phenotypes (A) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (B) Culture supernatants were collected on day 3 after cell seeding. IFN-γ and TNF-α levels secreted by CAR -T cells were measured by cytometric bead array. Data are presented as mean ± SD from multiple donors ( n = 3). (C) CD69 expression level of CAR-T cells on day 10 after seeding. Fluorescence intensity was quantified by flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (E) Expression levels of PD-1 and LAG-3 (surface markers), and TOX (intracellular marker) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining following fixation and permeabilization. Data are presented as mean ± SD from multiple donors ( n = 3). All statistical significance was assessed using a linear mixed-effects model with donor as a random effect and Tukey’s test.

    Article Snippet: The following antibodies were used: BioLegend, CD5-PE (clone UCHT2), CD69-PE (clone FN50), LAG3-FITC (Clone 7H2C65), mIgG2a-AF647 (clone RMG2a-62), and streptavidin-AF647; BD Biosciences, CD4-V500 (clone RPA-T4), CD8-V450 (clone RPA-T8), αβ TCR-PE (clone IP26), and γδ TCR-BV421 (clone 11F2); Thermo Fisher Scientific, PD-1-PE (clone J105) and CD27-PE (clone O323); Miltenyi Biotec, TOX-APC (clone REA473), Vδ1-PE-Cy7 (clone REA173), and Vδ2-V500 (clone 123R3); Cell Signaling Technology, Myc-AF647 or PE (clone 9B11).

    Techniques: Expressing, Fluorescence, Flow Cytometry, Marker, Staining

    Affinity-tuned A2 variants provide functional evidence that antigen-binding affinity plays a key role in regulating fratricide and T cell exhaustion (A) Binding level of recombinant anti-CD5 scFvs to CD5-positive and CD5-negative cell lines, as measured by flow cytometry. Data are presented as mean ± SD from technical replicates ( n = 3). (B) Affinity properties of anti-CD5 scFvs as determined by biolayer interferometry using Octet system. A2 scFv was used as controls. (For definitions of K D , K a , K dis , and curve fit parameters, refer to legend.) (C) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Culture supernatants were collected on day 3 to assess IFN-γ and TNF-α secretion, measured using cytometric bead array. Data are presented as mean ± SD from technical replicates ( n = 3). (E) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (F) CD69 expression levels in CAR-T cells on day 10 after cell seeding, measured by surface staining and flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (G) Expression levels of PD-1 and LAG-3 (surface markers) and TOX (intracellular) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining. Data are presented as mean ± SD from multiple donors ( n = 3). (H) 3 × 10 5 Myc + CAR-T cells were co-cultured with 1 × 10 5 Jurkat cells every 3–4 days for repeated antigen stimulation. Expansion of Myc + CAR-T cells was measured weekly by flow cytometry. Data are presented as mean ± SD from technical replicates ( n = 3). Statistical analyses were performed using one-way ANOVA with Tukey’s multiple comparisons test for (A, D, and H) and a linear mixed-effects model with donor as a random effect followed by Tukey’s test for (C–G).

    Journal: Molecular Therapy Oncology

    Article Title: Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells

    doi: 10.1016/j.omton.2026.201158

    Figure Lengend Snippet: Affinity-tuned A2 variants provide functional evidence that antigen-binding affinity plays a key role in regulating fratricide and T cell exhaustion (A) Binding level of recombinant anti-CD5 scFvs to CD5-positive and CD5-negative cell lines, as measured by flow cytometry. Data are presented as mean ± SD from technical replicates ( n = 3). (B) Affinity properties of anti-CD5 scFvs as determined by biolayer interferometry using Octet system. A2 scFv was used as controls. (For definitions of K D , K a , K dis , and curve fit parameters, refer to legend.) (C) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Culture supernatants were collected on day 3 to assess IFN-γ and TNF-α secretion, measured using cytometric bead array. Data are presented as mean ± SD from technical replicates ( n = 3). (E) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (F) CD69 expression levels in CAR-T cells on day 10 after cell seeding, measured by surface staining and flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (G) Expression levels of PD-1 and LAG-3 (surface markers) and TOX (intracellular) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining. Data are presented as mean ± SD from multiple donors ( n = 3). (H) 3 × 10 5 Myc + CAR-T cells were co-cultured with 1 × 10 5 Jurkat cells every 3–4 days for repeated antigen stimulation. Expansion of Myc + CAR-T cells was measured weekly by flow cytometry. Data are presented as mean ± SD from technical replicates ( n = 3). Statistical analyses were performed using one-way ANOVA with Tukey’s multiple comparisons test for (A, D, and H) and a linear mixed-effects model with donor as a random effect followed by Tukey’s test for (C–G).

    Article Snippet: The following antibodies were used: BioLegend, CD5-PE (clone UCHT2), CD69-PE (clone FN50), LAG3-FITC (Clone 7H2C65), mIgG2a-AF647 (clone RMG2a-62), and streptavidin-AF647; BD Biosciences, CD4-V500 (clone RPA-T4), CD8-V450 (clone RPA-T8), αβ TCR-PE (clone IP26), and γδ TCR-BV421 (clone 11F2); Thermo Fisher Scientific, PD-1-PE (clone J105) and CD27-PE (clone O323); Miltenyi Biotec, TOX-APC (clone REA473), Vδ1-PE-Cy7 (clone REA173), and Vδ2-V500 (clone 123R3); Cell Signaling Technology, Myc-AF647 or PE (clone 9B11).

    Techniques: Functional Assay, Binding Assay, Recombinant, Flow Cytometry, Expressing, Staining, Cell Culture

    High-affinity C7 variant-based CAR5 exhibited increased levels of both fratricide and T cell exhaustion compared to the C7 wild-type CAR5 (A) Binding level recombinant anti-CD5 scFvs to CD5-positive and CD5-negative cell lines, as measured by flow cytometry. Data are presented as pooled mean ± SD from technical replicates ( n = 3). (B) Affinity properties of anti-CD5 scFvs as determined by biolayer interferometry using Octet system. C7 scFv was used as controls. (For definitions of K D , K a , K dis , and curve fit parameters, refer to legend.) (C) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Culture supernatants were collected on day 3 to assess IFN-γ and TNF-α secretion, measured using cytometric bead array. Data are presented as mean ± SD from technical replicates ( n = 3). (E) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (F) CD69 expression levels in CAR-T cells on day 10 after cell seeding, measured by surface staining and flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (G) Expression levels of PD-1 and LAG-3 (surface markers) and TOX (intracellular) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining. Data are presented as mean ± SD from multiple donors ( n = 3). (H) 3 × 10 5 Myc + CAR-T cells were co-cultured with 1 × 10 5 Jurkat cells every 3–4 days for repeated antigen stimulation. Expansion of Myc + CAR-T cells was measured weekly by flow cytometry. Data are presented as mean ± SD from technical replicates ( n = 3). Statistical analyses were performed using one-way ANOVA with Tukey’s multiple comparisons test for (A, D, and H) and a linear mixed-effects model with donor as a random effect followed by Tukey’s test for (C–G).

    Journal: Molecular Therapy Oncology

    Article Title: Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells

    doi: 10.1016/j.omton.2026.201158

    Figure Lengend Snippet: High-affinity C7 variant-based CAR5 exhibited increased levels of both fratricide and T cell exhaustion compared to the C7 wild-type CAR5 (A) Binding level recombinant anti-CD5 scFvs to CD5-positive and CD5-negative cell lines, as measured by flow cytometry. Data are presented as pooled mean ± SD from technical replicates ( n = 3). (B) Affinity properties of anti-CD5 scFvs as determined by biolayer interferometry using Octet system. C7 scFv was used as controls. (For definitions of K D , K a , K dis , and curve fit parameters, refer to legend.) (C) Viability of CAR-T cells measured on day 3 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (D) Culture supernatants were collected on day 3 to assess IFN-γ and TNF-α secretion, measured using cytometric bead array. Data are presented as mean ± SD from technical replicates ( n = 3). (E) Total T cell number harvested on day 10 after cell seeding. Data are presented as mean ± SD from multiple donors ( n = 3). (F) CD69 expression levels in CAR-T cells on day 10 after cell seeding, measured by surface staining and flow cytometry. Data are presented as mean ± SD from multiple donors ( n = 3). (G) Expression levels of PD-1 and LAG-3 (surface markers) and TOX (intracellular) in CAR-T cells on day 10 after seeding. Surface markers were analyzed by flow cytometry, and TOX expression was assessed via intracellular staining. Data are presented as mean ± SD from multiple donors ( n = 3). (H) 3 × 10 5 Myc + CAR-T cells were co-cultured with 1 × 10 5 Jurkat cells every 3–4 days for repeated antigen stimulation. Expansion of Myc + CAR-T cells was measured weekly by flow cytometry. Data are presented as mean ± SD from technical replicates ( n = 3). Statistical analyses were performed using one-way ANOVA with Tukey’s multiple comparisons test for (A, D, and H) and a linear mixed-effects model with donor as a random effect followed by Tukey’s test for (C–G).

    Article Snippet: The following antibodies were used: BioLegend, CD5-PE (clone UCHT2), CD69-PE (clone FN50), LAG3-FITC (Clone 7H2C65), mIgG2a-AF647 (clone RMG2a-62), and streptavidin-AF647; BD Biosciences, CD4-V500 (clone RPA-T4), CD8-V450 (clone RPA-T8), αβ TCR-PE (clone IP26), and γδ TCR-BV421 (clone 11F2); Thermo Fisher Scientific, PD-1-PE (clone J105) and CD27-PE (clone O323); Miltenyi Biotec, TOX-APC (clone REA473), Vδ1-PE-Cy7 (clone REA173), and Vδ2-V500 (clone 123R3); Cell Signaling Technology, Myc-AF647 or PE (clone 9B11).

    Techniques: Variant Assay, Binding Assay, Recombinant, Flow Cytometry, Expressing, Staining, Cell Culture